177 related articles for article (PubMed ID: 19616540)
21. Inhibition of Stearoyl-CoA Desaturase 1 expression in human lung adenocarcinoma cells impairs tumorigenesis.
Scaglia N; Igal RA
Int J Oncol; 2008 Oct; 33(4):839-50. PubMed ID: 18813799
[TBL] [Abstract][Full Text] [Related]
22. Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat.
Broca C; Breil V; Cruciani-Guglielmacci C; Manteghetti M; Rouault C; Derouet M; Rizkalla S; Pau B; Petit P; Ribes G; Ktorza A; Gross R; Reach G; Taouis M
Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E463-71. PubMed ID: 15082420
[TBL] [Abstract][Full Text] [Related]
23. Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance.
Zinker B; Mika A; Nguyen P; Wilcox D; Ohman L; von Geldern TW; Opgenorth T; Jacobson P
Metabolism; 2007 Mar; 56(3):380-7. PubMed ID: 17292727
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of microsomal triglyceride transfer protein improves insulin sensitivity and reduces atherogenic risk in Zucker fatty rats.
Dhote V; Joharapurkar A; Kshirsagar S; Dhanesha N; Patel V; Patel A; Raval S; Jain M
Clin Exp Pharmacol Physiol; 2011 May; 38(5):338-44. PubMed ID: 21401695
[TBL] [Abstract][Full Text] [Related]
25. Endothelin antagonism improves hepatic insulin sensitivity associated with insulin signaling in Zucker fatty rats.
Berthiaume N; Carlson CJ; Rondinone CM; Zinker BA
Metabolism; 2005 Nov; 54(11):1515-23. PubMed ID: 16253642
[TBL] [Abstract][Full Text] [Related]
26. Recent progress in the discovery and development of stearoyl CoA desaturase inhibitors.
Uto Y
Chem Phys Lipids; 2016 May; 197():3-12. PubMed ID: 26344107
[TBL] [Abstract][Full Text] [Related]
27. Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy.
Roongta UV; Pabalan JG; Wang X; Ryseck RP; Fargnoli J; Henley BJ; Yang WP; Zhu J; Madireddi MT; Lawrence RM; Wong TW; Rupnow BA
Mol Cancer Res; 2011 Nov; 9(11):1551-61. PubMed ID: 21954435
[TBL] [Abstract][Full Text] [Related]
28. Vitamin A regulates obesity in WNIN/Ob obese rat; independent of stearoyl-CoA desaturase-1.
Jeyakumar SM; Vajreswari A; Giridharan NV
Biochem Biophys Res Commun; 2008 May; 370(2):243-7. PubMed ID: 18364238
[TBL] [Abstract][Full Text] [Related]
29. A model cell line to study regulation of stearoyl-CoA desaturase gene 1 expression by insulin and polyunsaturated fatty acids.
Ntambi JM; Sessler AM; Takova T
Biochem Biophys Res Commun; 1996 Mar; 220(3):990-5. PubMed ID: 8607881
[TBL] [Abstract][Full Text] [Related]
30. Delta-6 desaturase activity and gene expression, tissue fatty acid profile and glucose turnover rate in hereditary hypertriglyceridemic rats.
Demcakova E; Sebokova ; Ukropec J; Gasperikova D; Klimes I
Endocr Regul; 2001 Dec; 35(4):179-86. PubMed ID: 11858764
[TBL] [Abstract][Full Text] [Related]
31. COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver.
Hsieh PS; Jin JS; Chiang CF; Chan PC; Chen CH; Shih KC
Obesity (Silver Spring); 2009 Jun; 17(6):1150-7. PubMed ID: 19247274
[TBL] [Abstract][Full Text] [Related]
32. Thiazole analog as stearoyl-CoA desaturase 1 inhibitor.
Li CS; Belair L; Guay J; Murgasva R; Sturkenboom W; Ramtohul YK; Zhang L; Huang Z
Bioorg Med Chem Lett; 2009 Sep; 19(17):5214-7. PubMed ID: 19632834
[TBL] [Abstract][Full Text] [Related]
33. Obesity resistance of the stearoyl-CoA desaturase-deficient (scd1-/-) mouse results from disruption of the epidermal lipid barrier and adaptive thermoregulation.
Binczek E; Jenke B; Holz B; Günter RH; Thevis M; Stoffel W
Biol Chem; 2007 Apr; 388(4):405-18. PubMed ID: 17391062
[TBL] [Abstract][Full Text] [Related]
34. Bicyclic heteroaryl inhibitors of stearoyl-CoA desaturase: from systemic to liver-targeting inhibitors.
Ramtohul YK; Powell D; Leclerc JP; Leger S; Oballa R; Black C; Isabel E; Li CS; Crane S; Robichaud J; Guay J; Guiral S; Zhang L; Huang Z
Bioorg Med Chem Lett; 2011 Oct; 21(19):5692-6. PubMed ID: 21871798
[TBL] [Abstract][Full Text] [Related]
35. Hormonal regulation of stearoyl coenzyme-A desaturase 1 activity and gene expression in primary cultures of chicken hepatocytes.
Lefevre P; Diot C; Legrand P; Douaire M
Arch Biochem Biophys; 1999 Aug; 368(2):329-37. PubMed ID: 10441384
[TBL] [Abstract][Full Text] [Related]
36. Probing the role of stearoyl-CoA desaturase-1 in hepatic insulin resistance.
Flowers MT; Miyazaki M; Liu X; Ntambi JM
J Clin Invest; 2006 Jun; 116(6):1478-81. PubMed ID: 16741573
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological activity of a potent and orally bioavailable SCD inhibitor (MF-438).
Léger S; Black WC; Deschenes D; Dolman S; Falgueyret JP; Gagnon M; Guiral S; Huang Z; Guay J; Leblanc Y; Li CS; Massé F; Oballa R; Zhang L
Bioorg Med Chem Lett; 2010 Jan; 20(2):499-502. PubMed ID: 20004097
[TBL] [Abstract][Full Text] [Related]
38. The role of stearoyl-CoA desaturase in the control of metabolism.
Dobrzyn A; Ntambi JM
Prostaglandins Leukot Essent Fatty Acids; 2005 Jul; 73(1):35-41. PubMed ID: 15941655
[TBL] [Abstract][Full Text] [Related]
39. Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat.
Minoura H; Takeshita S; Yamamoto T; Mabuchi M; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Ita M; Mutoh S
Eur J Pharmacol; 2005 Sep; 519(1-2):182-90. PubMed ID: 16039648
[TBL] [Abstract][Full Text] [Related]
40. Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery.
Brown JM; Rudel LL
Curr Opin Lipidol; 2010 Jun; 21(3):192-7. PubMed ID: 20216310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
